(Q39883370)

15 September 2017

title

Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy (English)

1 reference

15 September 2017

4

1 reference

15 September 2017

Sun-Ouck Kim

1

1 reference

15 September 2017

Taek Won Kang

series ordinal

2

1 reference

15 September 2017

Dongdeuk Kwon

series ordinal

3

1 reference

15 September 2017

Soo Bang Ryu

series ordinal

5

1 reference

15 September 2017

publication date

1 March 2009

1 reference

International Brazilian Journal of Urology

15 September 2017

published in

1 reference

15 September 2017

volume

35

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

183-8; discussion 189

1 reference

Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Tumor cell interactions with the extracellular matrix during invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Immunologic aspects of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Runx2, a multifunctional transcription factor in skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

The genetic transformation of bone biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Development of TGF-beta signalling inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Prognostic value of serum hormone concentrations in prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Management of Bone Loss in Men With Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

Risk factors for male osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382009000200008

10.1590/S1677-55382009000200008

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference